Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jie Wang, PhD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Affiliated Hospital of Hebei University
Baoding, China
Recruiting - Beijing Cancer Hospital
Beijing, China
Recruiting - Beijing Friendship Hospital, Capital Medical University
Beijing, China
Recruiting - Beijing Tongren Hospital
Beijing, China
Recruiting - Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, China
Recruiting - Peking University International Hospital
Beijing, China
Recruiting - the Fifth Medical Center of Pla Ceneral Hospital
Beijing, China
Recruiting - the First Affiliated Hospital of Bengbu Medical College
Bengbu, China
Recruiting - the First Affiliated Hospital of Bengbu Medical University
Bengbu, China
Recruiting - Cangzhou Hospital of Integrated Tcm-Wm·hebei
Cangzhou, China
Recruiting - Ji Lin Cancer Hospital
Changchun, China
Recruiting - Hunan Cancer Hospital
Changsha, China
Recruiting - the Second Xiangya Hospital of Central South University
Changsha, China
Recruiting - Xiangya Hospital of Central South University
Changsha, China
Recruiting - Sichuan Cancer Hospital
Chengdu, China
Recruiting - West China Hospital, Sichuan University
Chengdu, China
Recruiting - Chifeng Municipal Hospital
Chifeng, China
Recruiting - Army Medical Center of Pla
Chongqing, China
Recruiting - Chongqing University Cancer Hospital
Chongqing, China
Recruiting - China-Japan Union Hospitai of Jilin University
Ch’ang-ch’un, China
Recruiting - the First Affiliated Hospital of Dalian Medical University
Dalian, China
Recruiting - Fujian Cancer Hospital
Fuzhou, China
Recruiting - Fuzhou Pulmonary Hospital of Fujian
Fuzhou, China
Recruiting - the 900 Hospital of the Joint Service Support Force of the People'S Liberation Army of China
Fuzhou, China
Recruiting - First Affiliated Hospital of Gannan Medical University
Ganzhou, China
Recruiting - Guangdong Province Traditional Chinese Medical Hospital
Guangzhou, China
Recruiting - Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, China
Recruiting - the Frist Affiliated Hospital of Guangzhou Medical College
Guangzhou, China
Recruiting - the Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, China
Recruiting - Cancer Hospital of the University of Chinese Academy of Sciences
Hangzhou, China
Recruiting - the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Recruiting - the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, China
Recruiting - Hanzhong Central Hospital
Hanzhong, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, China
Recruiting - Cancer Hospital Affiliated To Harbin Medical University
Ha’erbin, China
Recruiting - Harbin Medical University Cancer Hospital
Ha’erbin, China
Recruiting - the Second Hospital of Anhui Medical University
Hefei, China
Recruiting - Henan Cancer Hospital (affiliated Cancer Hospital of Zhengzhou University)
Henan, China
Recruiting - Inner Mongolia People'S Hospital
Hohhot, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Sept 2021
- Primary completion
- 30 Apr 2028
- Completion
- 30 Dec 2028
- Last update posted
- 10 Feb 2026
- Registered enrollment
- 400
- Registry id
- NCT04930432
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.